Tim Cope Email & Phone Number

Philadelphia, Pa, Us

Paris, Île-De-France, Fr

Responsible for the Cardiology Business Unit and launch readiness for bentracimab, a potential first-in-class reversal agent for the antiplatelet effects of ticagrelor.

Paris, France, Fr

Paris, France, Fr

Paris, France, Fr

Cambridge, Ma, Us

- Leading U.S. HCP Marketing efforts for the commercialization of Sotatercept in pulmonary arterial hypertension including Market Development Strategy, KOL Engagement Strategy, HCP Targeting and Segmentation, Congress Strategy, etc. - Immediately upon starting in role, completed HCP audit review across 5 domains that included 15 pieces of qualitative and quantitative research in order to synthesize current understanding of PAH landscape and begin forming areas of focus- Created 18-month HCP Market Development Strategic Plan grounded on the principles of Educating and Learning. Educating providers on specific disease state elements identified through annual brand planning process and Learning about out HCPs universe to address gaps in available data- Leading cross-functional team through KOL Engagement planning process which includes identifying the top KOLs, understanding meaningful ways to engage them and the development of individually curated 12-month engagement plans - Created HCP Customer Belief System identifying the current beliefs and behaviors of target HCPs and the belief / behavior shifts we are seeking to achieve in the market

Tokyo, Jp

- Market access and channel strategy lead for the Gastroenterology Business Unit for an inline rare disease product for short bowel syndrome and an investigational allogeneic stem cell therapy for the treatment of Crohn's perianal fistula - Led cross-functional project to improve the patient onboarding process for Gattex to help address above average early discontinuation rate through education delivered in collaboration with patient services and specialty pharmacy partners - Developed market access loss of exclusivity (LOE) strategy to help ensure greater than 80% of current patients were able to maintain access to therapy minimizing disruption at time of patent loss while simultaneously preserving net sales - Executed payer policy analysis to uncover payers who's policies included criteria that were inappropriately impacting patients ability to start and stay on therapy - Designed foundational market access strategy to support launch of novel cell therapy including pricing strategy, payer strategy and distribution modeling

Tokyo, Jp

- Led the development and execution of integrated commercialization strategy and plan for the launch of Entyvio Subq – an investigational new route of administration for the $2.5 billion Entyvio Family- Developed evolved strategy and positioning for the Entyvio Family that focused on continued support and utilization from current prescribers while simultaneously reaching new providers who historically have not demonstrated a propensity to utilize infused therapies - Designed coverage assistance and specialty pharmacy program to support patients moving from Entyvio IV to Entyvio Subq allowing a frictionless transition from medical to pharmacy benefit- Led development of new campaign and messaging platform, built from qualitative insights, positioning Entyvio as the leader within IBD as the #1 prescribed brand for new starts and switches- Orchestrated HCP targeting and segmentation initiative to inform strategic priorities with customer universe ensuring ability to reach new growth with additional Entyvio formulation - Led competitive preparedness initiatives to ready the GI organization for an unprecedented burst of innovation expected within the IBD landscape including new molecular entities, routes of administration and clinical trial designs

Tokyo, Jp

- Initiated strategic development and tactical execution of HCP promotions of multibillion-dollar global brand - Owned and evolved Entyvio branded communications to HCP customers across personal and non-personal channels, including rep-delivered, online/digital, and congress channel- Led evolution of Entyvio HCP promotional story which included infusing new data andresources aligned to strategic brand positioning- Directed congress strategy which resulted in Entyvio being recognized as the top brand atDDW 2019- Led competitive planning activities which aided in development of strategies andtactics to continue fortifying 1st line positioning despite a new competitive entrant

Tokyo, Jp

- Led strategic and tactical execution of brand strategy across personal and nonpersonalchannels as well as competitive planning and special projects.- Developed indication-based opportunities which helped Entyvio close a $35M gapfor the Fiscal Year and accelerated bio-naïve share growth in UC by 6% -- and now the market leader with a +39% bio-naïve market share- Created patient identification platform aimed at helping physicians identify patientsready for biologic to point to Entyvio- Partnered with insights colleague to execute research focused on understandingEntyvio’s access perceptions – research led to the development of EntyvioStart andEntyvioConnect Bridge Programs-Launched EntyvioHome pilot program which was designed to provide patients with anenhanced home infusion experience

Tokyo, Jp

- Led team of twelve Sales Reps across central PA through multiple product launches in neuroscience, endocrinology and gastroenterology - Propelled team into cresset ranking prior to being promoted onto the Entyvio Marketing team - Selected by Regional Director and Area Vice President to lead multiple initiatives throughout tenure including mentoring newly hired district managers

Tokyo, Jp

- Co‐led development and implementation of launch training program for cardiovascular asset - Led Initial Sales Training Program Development for contract sales force - Co-led continuing education program for sales representative

Tokyo, Jp

- Won Takeda's version of President's club 3 out of 6 years in sales - Promoted to Senior Sales Representative and Territory Manager during sales tenure- Led multiple regional and national initiatives prior to being promoted to National SalesTrainer